Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study
Authors:
- Alomgir HossainAlomgir Hossain
- Ekhtiar RahmanEREkhtiar Rahman
- Omar FaruqeOmar Faruqe
- Ahmed SaifASAhmed Saif
- Suzzada SuhiSSSuzzada Suhi
- Rashed ZamanRashed Zaman
- Abdurahman Hajinur HiradAHAbdurahman Hajinur Hirad
- Mohammad Nurul MatinMohammad Nurul Matin
- Muhammad Fazle RabbeeMuhammad Fazle Rabbee
- Kwang-Hyun BaekKwang-Hyun Baek
Open Access
- 1 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 483
Abstract
Diabetes, characterized by elevated blood sugar levels, poses significant health and economic risks, correlating with complications like cardiovascular disease, kidney failure, and blindness. Dipeptidyl peptidase-4 (DPP-4), also referred to as T-cell activation antigen CD26 (EC 3.4.14.5.), plays a crucial role in glucose metabolism and immune function. Inhibiting DPP-4 was anticipated as a potential new therapy for diabetes. Therefore, identification of plant-based natural inhibitors of DPP-4 would help in eradicating diabetes worldwide. Here, for the identification of the potential natural inhibitors of DPP-4, we developed a phytochemicals library consisting of over 6000 phytochemicals detected in 81 medicinal plants that exhibited anti-diabetic potency. The library has been docked against the target proteins, where isorhamnetin, Benzyl 5-Amino-5-deoxy-2,3-O-isopropyl-alpha-D-mannofuranoside (DTXSID90724586), and 5-Oxo-7-[4-(trifluoromethyl) phenyl]-4H,6H,7H-[1,2]thiazolo[4,5-b]pyridine 3-carboxylic acid (CHEMBL3446108) showed binding affinities of −8.5, −8.3, and −8.3 kcal/mol, respectively. These compounds exhibiting strong interactions with DPP-4 active sites (Glu205, Glu206, Tyr547, Trp629, Ser630, Tyr662, His740) were identified. ADME/T and bioactivity predictions affirmed their pharmacological safety. Density functional theory calculations assessed stability and reactivity, while molecular dynamics simulations demonstrated persistent stability. Analyzing parameters like RMSD, RG, RMSF, SASA, H-bonds, MM-PBSA, and FEL confirmed stable protein–ligand compound formation. Principal component analysis provided structural variation insights. Our findings suggest that those compounds might be possible candidates for developing novel inhibitors targeting DPP-4 for treating diabetes.Keywords
Funding Information
- King Saud University, Riyadh, Saudi Arabia (RSPD2024R677)
This publication has 106 references indexed in Scilit:
- A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER studyDiabetologia, 2021
- Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasomePhytotherapy Research, 2021
- Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseasesJournal of Cellular Physiology, 2020
- Pathophysiology, Differential Diagnosis, and Treatment of Diabetic DiarrheaDigestive Diseases and Sciences, 2019
- Association Between Antipsychotic Medication Use and DiabetesCurrent Diabetes Reports, 2019
- On homology modeling of the M2 muscarinic acetylcholine receptor subtypeJournal of Computer-Aided Molecular Design, 2013
- Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area MethodMolecular Informatics, 2012
- Understanding drug‐likenessWIREs Computational Molecular Science, 2011
- Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingJournal of Computational Chemistry, 2010
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996